PATENT CLAIM ANALYSIS

Application Number: 15978692
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).

Claim (Index 7):
The pooled plasma composition of  claim 6 , wherein less than 50% of the 1000 or more plasma samples are from high titer selected human plasma donors.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 93.0
- Lexical Diversity: 1.82
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14592727', '14790872', '15811486', '14592721', '15460147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8855249550567791
- 35 USC 102 Novelty (BERT): 0.6676498622348686
- Combined Prediction Score: 0.863737445774588
- Mean Citation Score: 677.0751379999998
- Max Citation Score: 774.59973
- Similarity Product: 471.59981136864064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test